These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 8856748)

  • 21. Antimicrobial resistance profile of bacterial isolates from Intensive Care Unit: changing trends.
    Anupurba S; Sen MR
    J Commun Dis; 2005 Mar; 37(1):58-65. PubMed ID: 16637402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of antimicrobial use pattern in the intensive treatment unit of a teaching hospital in western Nepal.
    Shankar PR; Partha P; Shenoy N; Brahmadathan KN
    Am J Infect Control; 2003 Nov; 31(7):410-4. PubMed ID: 14639438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The intensive care unit is a hot zone for antibiotic resistance].
    Hanberger H; Nilsson LE
    Lakartidningen; 1999 Mar; 96(11):1276-7. PubMed ID: 10194899
    [No Abstract]   [Full Text] [Related]  

  • 24. [Big differences when it comes to antibiotic resistance between European intensive care units].
    Hanberger H
    Lakartidningen; 2001 Oct; 98(44):4827-8. PubMed ID: 11729794
    [No Abstract]   [Full Text] [Related]  

  • 25. Antimicrobial susceptibility profiles of clinically relevant blood culture isolates from nine surgical intensive care units, 1996-2000.
    Assadian O; Apfalter P; Assadian A; Makristathis A; Daxboeck F; Koller W; Hirschl AM
    Eur J Clin Microbiol Infect Dis; 2002 Oct; 21(10):743-7. PubMed ID: 12415474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prevalence and in vitro antimicrobial susceptibility patterns of Acinetobacter baumannii strains in a Moroccan university hospital].
    Lahsoune M; Boutayeb H; Zerouali K; Belabbes H; El Mdaghri N
    Med Mal Infect; 2007 Dec; 37(12):828-31. PubMed ID: 17669611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Bacteriologic and clinical analysis of nosocomial infections in patients from the intensive care unit].
    Nikodemski T
    Ann Acad Med Stetin; 1999; 45():211-26. PubMed ID: 10909491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Daily cost of antimicrobial therapy in patients with Intensive Care Unit-acquired, laboratory-confirmed bloodstream infection.
    Vandijck DM; Depaemelaere M; Labeau SO; Depuydt PO; Annemans L; Buyle FM; Oeyen S; Colpaert KE; Peleman RP; Blot SI; Decruyenaere JM
    Int J Antimicrob Agents; 2008 Feb; 31(2):161-5. PubMed ID: 18164599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimicrobial resistance prevalence rates in hospital antibiograms reflect prevalence rates among pathogens associated with hospital-acquired infections.
    Fridkin SK; Edwards JR; Tenover FC; Gaynes RP; McGowan JE; ;
    Clin Infect Dis; 2001 Aug; 33(3):324-30. PubMed ID: 11438897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efforts of pharmacy to reduce antibiotic resistance.
    Klem C; Dasta JF
    New Horiz; 1996 Aug; 4(3):377-84. PubMed ID: 8856756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CDC's campaign to prevent antimicrobial resistance in health-care settings.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Apr; 51(15):343. PubMed ID: 12004862
    [No Abstract]   [Full Text] [Related]  

  • 32. Antimicrobial resistance in the ICU: The time for action is now.
    Kollef M; Niederman M
    Crit Care Med; 2001 Apr; 29(4 Suppl):N63. PubMed ID: 11292877
    [No Abstract]   [Full Text] [Related]  

  • 33. Canada tackles antimicrobial resistance.
    Murray T
    CMAJ; 2014 Dec; 186(18):1351. PubMed ID: 25404392
    [No Abstract]   [Full Text] [Related]  

  • 34. Introduction--infection and critical illness: genetic and environmental aspects of susceptibility and resistance.
    Bion JF; Brun-Buisson C
    Intensive Care Med; 2000; 26 Suppl 1():S1-2. PubMed ID: 10786950
    [No Abstract]   [Full Text] [Related]  

  • 35. Antimicrobial resistance: factors and outcomes.
    Fish DN; Ohlinger MJ
    Crit Care Clin; 2006 Apr; 22(2):291-311, vii. PubMed ID: 16678001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Nosocomial infections at intensive care units. Don't give germs a chance!].
    Sandrock B
    Krankenpfl Soins Infirm; 1999 May; 92(5):8-11. PubMed ID: 10514685
    [No Abstract]   [Full Text] [Related]  

  • 37. Effectiveness of programs to decrease antimicrobial resistance in the intensive care unit.
    Hall CS; Ost DE
    Semin Respir Infect; 2003 Jun; 18(2):112-21. PubMed ID: 12840792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals.
    Fridkin SK; Steward CD; Edwards JR; Pryor ER; McGowan JE; Archibald LK; Gaynes RP; Tenover FC
    Clin Infect Dis; 1999 Aug; 29(2):245-52. PubMed ID: 10476720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial resistance: an overview.
    Solomkin JS
    New Horiz; 1996 Aug; 4(3):319-20. PubMed ID: 8856748
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.